|
|
amine metabolic process
|
GO:0009308 |
45 |
0.793
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.631
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.597
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.571
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.511
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.504
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.497
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.483
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.466
|
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.457
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.449
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.442
|
Mouse |
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.412
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.412
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.399
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.398
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.387
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.387
|
Human |
|
|
skin development
|
GO:0043588 |
220 |
0.381
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.366
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.358
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.348
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.348
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.334
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.329
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.325
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.317
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.316
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.313
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.310
|
Mouse |
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.309
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.303
|
Human |
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.299
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.291
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.291
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.283
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.281
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.280
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.280
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.276
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.271
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.270
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.269
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.267
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.266
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.263
|
Mouse |
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.261
|
|
|
|
response to sterol
|
GO:0036314 |
4 |
0.259
|
Rat |
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.259
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.257
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.251
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.242
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.237
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.236
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.236
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.235
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.233
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.231
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.231
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.228
|
Mouse |
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.225
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.224
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.223
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.223
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.220
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.219
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.219
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.218
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.213
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.207
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.206
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.205
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.204
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.202
|
|
|
|
progesterone secretion
|
GO:0042701 |
1 |
0.200
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.198
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.195
|
Mouse |
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.194
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.194
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.192
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.191
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.187
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.187
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.186
|
|
|
|
mesonephric tubule morphogenesis
|
GO:0072171 |
63 |
0.185
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.183
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.183
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.182
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.180
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.178
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.176
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.176
|
|
|
|
ovarian follicle development
|
GO:0001541 |
40 |
0.172
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.170
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.170
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.169
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.168
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.166
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.165
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.163
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.162
|
Rat |
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.160
|
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.152
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.150
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.149
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.149
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.148
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.141
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.137
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.136
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.135
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.135
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.132
|
Mouse |
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.131
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.131
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.130
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.129
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.126
|
|
|
|
follicle stimulating hormone secretion
|
GO:0046884 |
1 |
0.125
|
Human |
|
|
response to cholesterol
|
GO:0070723 |
4 |
0.125
|
Rat |
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.125
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.124
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.122
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.121
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.121
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.120
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.120
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.120
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.120
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.119
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.118
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.118
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.117
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.116
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.116
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.115
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.115
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.114
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.114
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.113
|
|
|
|
activin receptor signaling pathway
|
GO:0032924 |
18 |
0.113
|
Human |
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.113
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.112
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.112
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.112
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.111
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.111
|
|
|
|
negative regulation of activin receptor signaling pathway
|
GO:0032926 |
6 |
0.110
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.110
|
|
|
|
otic placode formation
|
GO:0043049 |
1 |
0.109
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.108
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.108
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.108
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.108
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.108
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.108
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.107
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.107
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.107
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
31 |
0.107
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.106
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.106
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.105
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.105
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.104
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.103
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.103
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.102
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.102
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.101
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.101
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.101
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.100
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.100
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.099
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.099
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.099
|
|
|
|
metanephric nephron epithelium development
|
GO:0072243 |
19 |
0.099
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.099
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.099
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.098
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.098
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.097
|
|
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.097
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.096
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.096
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.095
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.095
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.095
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.093
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.093
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.093
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.092
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.092
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.092
|
|
|
|
positive regulation of mesonephros development
|
GO:0061213 |
20 |
0.092
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.092
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.091
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.090
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.090
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.090
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.090
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.089
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.089
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.088
|
Mouse |
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.087
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.087
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.087
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.087
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.087
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.087
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.086
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.086
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.085
|
Human |
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.085
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.085
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.085
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.084
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.084
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.084
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.083
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.083
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.083
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.083
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.083
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.082
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.082
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.082
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.082
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.080
|
|
|
|
ureteric bud morphogenesis
|
GO:0060675 |
62 |
0.080
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.080
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.079
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.079
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.079
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.079
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.079
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.079
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.078
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.078
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.078
|
|
|
|
metanephric nephron development
|
GO:0072210 |
34 |
0.077
|
|
|
|
regulation of hair cycle
|
GO:0042634 |
11 |
0.077
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.077
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.076
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.076
|
|
|
|
negative regulation of reproductive process
|
GO:2000242 |
31 |
0.076
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.076
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.075
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.075
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.075
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.075
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.074
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.074
|
Human |
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.074
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.073
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.073
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.073
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.073
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.072
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.072
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.072
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.072
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.071
|
Mouse |
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.071
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.071
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.071
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.070
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.070
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.070
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.070
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
8 |
0.070
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.069
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.069
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.069
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.069
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.069
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.069
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.068
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.068
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.068
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.068
|
Mouse |
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.068
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.068
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.068
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.068
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.067
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.067
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.067
|
|
|
|
lung alveolus development
|
GO:0048286 |
45 |
0.067
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.067
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.066
|
Human |
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.066
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
21 |
0.066
|
|
|
|
paraxial mesoderm development
|
GO:0048339 |
18 |
0.066
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.066
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.066
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.065
|
|
|
|
positive regulation of reproductive process
|
GO:2000243 |
19 |
0.065
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.065
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.065
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.065
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.065
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.064
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.064
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.064
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.064
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.064
|
|
|
|
regulation of hair follicle development
|
GO:0051797 |
9 |
0.064
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.064
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.064
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.063
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.063
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.063
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.063
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.063
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.063
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.062
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.062
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.062
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.062
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.062
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.062
|
|
|
|
positive regulation of kidney development
|
GO:0090184 |
28 |
0.061
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.061
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.061
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.061
|
Rat |
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.061
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.061
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.061
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.060
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.060
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.060
|
|
|
|
positive regulation of synapse assembly
|
GO:0051965 |
18 |
0.060
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.060
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.060
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.060
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.060
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.059
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.059
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.059
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.059
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.059
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.059
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.059
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.059
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.059
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.059
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.059
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.058
|
|
|
|
neural crest cell development
|
GO:0014032 |
48 |
0.058
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.058
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.058
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.058
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.058
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.057
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.057
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.056
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.056
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.056
|
|
|
|
positive regulation of inositol phosphate biosynthetic process
|
GO:0060732 |
2 |
0.056
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.056
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.056
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.056
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.055
|
|
|
|
positive regulation of cytoskeleton organization
|
GO:0051495 |
49 |
0.055
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.055
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.055
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.055
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.055
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.055
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
10 |
0.054
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.054
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.054
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.054
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.054
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.054
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.054
|
|
|
|
positive regulation of hair cycle
|
GO:0042635 |
7 |
0.053
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.053
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.053
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.053
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.052
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.052
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.052
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.052
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.052
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.051
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.051
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.051
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.051
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.051
|
|
|
|
regulation of fibroblast growth factor production
|
GO:0090270 |
4 |
0.051
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.051
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.051
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.051
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.050
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.050
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.050
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.050
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.049
|
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.049
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.049
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.049
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.049
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.049
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.049
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.048
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.048
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.048
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.048
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.048
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.048
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.048
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.047
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.047
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.047
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.047
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.047
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.047
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.047
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.047
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.047
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.047
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.046
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.046
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.046
|
|
|
|
regulation of chondrocyte differentiation
|
GO:0032330 |
33 |
0.046
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.046
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.046
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.046
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.046
|
|
|
|
regulation of protein tyrosine kinase activity
|
GO:0061097 |
17 |
0.046
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.046
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.045
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.045
|
|
|
|
positive regulation of bmp signaling pathway
|
GO:0030513 |
23 |
0.045
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.045
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.045
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.045
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.045
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.045
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.045
|
|
|
|
regulation of inositol phosphate biosynthetic process
|
GO:0010919 |
3 |
0.045
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.045
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.045
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.045
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.045
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.045
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.045
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.045
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.044
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.044
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.044
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.044
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.044
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.044
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.044
|
|
|
|
erbb signaling pathway
|
GO:0038127 |
32 |
0.044
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.044
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.044
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.043
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
53 |
0.043
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.043
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.043
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.043
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.043
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.043
|
|
|
|
b cell proliferation
|
GO:0042100 |
53 |
0.043
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.043
|
|
|
|
t cell receptor signaling pathway
|
GO:0050852 |
46 |
0.043
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.042
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.042
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.042
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.042
|
Human |
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.042
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.042
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.042
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.042
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.042
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.042
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.042
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.042
|
|
|
|
anatomical structure arrangement
|
GO:0048532 |
20 |
0.041
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.041
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.041
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.041
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.041
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.041
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.041
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.041
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.041
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.041
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.041
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.041
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.041
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.040
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.040
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.040
|
|
